For healthcare professionals

This website is a global information resource. It is intended for healthcare professionals outside of the United States of America (US) and the United Kingdom (UK) who are interested in information on VABYSMO®. This website is not country-specific and therefore may contain information which is not applicable to your country. Please refer to your local Prescribing Information for full details.

Now Approved

Drying Data

VABYSMO^®▼ has reached more than 100 countries with a total of over 8 million doses distributed in just 3 years.^1,2

Celebrate this milestone in style and with music!

Drying Data

VABYSMO^®▼ has reached more than 100 countries with a total of over 8 million doses distributed in just 3 years.^1,2

Celebrate this milestone in style and with music!

References

Hatz K, et al. SOG-Jahreskongress 2025.
Vabysmo (faricimab) SmPC. Roche Registration GmbH; 2022.

This website contains information on products that is targeted to a wide range of audiences, and may contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration or usage in your country of origin.

This website is a global information resource for a public audience, outside of the United States of America and the United Kingdom. This website is produced by Roche and is not intended to provide medical advice and/or treatment guidance. The content on this website is non-promotional and does not make specific reference to the availability or the use of a medicine.

▼ This medicinal product is subject to additional monitoring.